MicroRNAs as Biomarkers for Obstructive Sleep Apnea
Recruiting now
Conditions studied: Obstructive Sleep Apnea
In brief
Although obstructive sleep apnea (OSA) is a common disorder, there are no blood biomarkers for identification and management of these patients. This project will study microRNAs in order to develop and validate blood biomarkers that are specific to OSA, useful for identification of cases with OSA, reflective of efficacy of therapy, and able to predict blood pressure response to treatment of OSA.
Key facts
- Study ID
- NCT06189755
- Run by
- University of Pennsylvania
- People needed
- 500
- Starts
- 2024-04-01
- Expected to finish
- 2028-04-30
- Last updated by the study team
- 2026-08-03
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- The Ohio State University - Martha Morehouse Medical Pavilion, Suite 2600 — Columbus, Ohio, United States (enrolling)
- University of Pennsylvania — Philadelphia, Pennsylvania, United States (enrolling)
- University of Iceland — Reykjavik, Iceland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.